Femasys is trading 9.35% down at $2.52 as broad risk-off pressure pushed major U.S. indexes lower in pre-market trading.
- No fresh company-specific announcement was identified on September 14, 2026; the latest reported company news was its September 9 CapexMD partnership.
- The move appears aligned with technology selling, higher oil prices, and uncertainty ahead of Tuesdayβs Federal Reserve decision.
- Pre-market activity is significant, but no volume data was provided.